(Q37778667)

23 August 2017

1 reference

title

Personalized medicine: marking a new epoch in cancer patient management (English)

1 reference

23 August 2017

Personalized Medicine: Marking a New Epoch in Cancer Patient Management (English)

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

18 June 2024

1 reference

0 references

personalized medicine

1 reference

Maria Diamandis

1

1 reference

23 August 2017

Nicole M. A. White

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693306

18 June 2024

George M. Yousef

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693306

18 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20693306

18 June 2024

publication date

6 August 2010

1 reference

full work available at URL

23 August 2017

https://aacrjournals.org/mcr/article-pdf/8/9/1175/3146749/1175.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693306

http://mcr.aacrjournals.org/cgi/content/abstract/8/9/1175

18 June 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20693306

https://aacrjournals.org/mcr/article-pdf/8/9/1175/3146749/1175.pdf

18 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Molecular Cancer Research

18 June 2024

published in

1 reference

23 August 2017

volume

8

1 reference

23 August 2017

issue

9

1 reference

23 August 2017

page(s)

1175-1187

1 reference

A second generation human haplotype map of over 3.1 million SNPs

23 August 2017

cites work

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE06258

International network of cancer genome projects

30 October 2021

1 reference

31 March 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE08987

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/35000501

The consensus coding sequences of human breast and colorectal cancers

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1133427

Molecular classification of cutaneous malignant melanoma by gene expression profiling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/35020115

The complete genome of an individual by massively parallel DNA sequencing

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE06884

Genomic signatures to guide the use of chemotherapeutics.

15 July 2023

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1038/NM1491

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1016/S1470-2045(07)70345-5

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1056/NEJMOA060467

Finishing the euchromatic sequence of the human genome

1

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

A haplotype map of the human genome

18 June 2024

2

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

The Personalized Medicine Coalition: goals and strategies

18 June 2024

4

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

The case for personalized medicine

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Personalized medicine: revolutionizing drug discovery and patient care

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Is personalized medicine finally arriving?

18 June 2024

7

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genomic and personalized medicine: foundations and applications

18 June 2024

8

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Tumor heterogeneity and the biology of cancer invasion and metastasis

18 June 2024

9

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Utilizing the molecular gateway: the path to personalized cancer management.

18 June 2024

10

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Environment and cancer: who are susceptible?

18 June 2024

11

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice.

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

18 June 2024

15

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

18 June 2024

16

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer

18 June 2024

17

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers

18 June 2024

18

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer

18 June 2024

19

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study

18 June 2024

20

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells

18 June 2024

21

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Mutations predisposing to hereditary nonpolyposis colorectal cancer

18 June 2024

22

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

18 June 2024

23

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

18 June 2024

24

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers

18 June 2024

25

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification

18 June 2024

26

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group

18 June 2024

27

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Pathobiology and Molecular Profiling of Peripheral T-Cell Lymphomas

18 June 2024

28

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Gene expression profiling in acute myeloid leukemia

18 June 2024

29

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Presenting features of breast cancer differ by molecular subtype

18 June 2024

32

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Prognostic applications of gene expression signatures in breast cancer

18 June 2024

33

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer

18 June 2024

34

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma

18 June 2024

35

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Molecular diagnosis of Burkitt's lymphoma

18 June 2024

36

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

18 June 2024

37

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

18 June 2024

38

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts

18 June 2024

39

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

18 June 2024

40

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

18 June 2024

41

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors

18 June 2024

42

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

18 June 2024

43

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

18 June 2024

44

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

18 June 2024

45

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy

18 June 2024

46

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Lessons from Tarceva in pancreatic cancer: where are we now, and how should future trials be designed in pancreatic cancer?

18 June 2024

47

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Pharmacogenomics: translating functional genomics into rational therapeutics

18 June 2024

48

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment

18 June 2024

49

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Polymorphism of cytochrome P450 and xenobiotic toxicity

18 June 2024

50

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

18 June 2024

51

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Impaired tamoxifen metabolism reduces survival in familial breast cancer patients

18 June 2024

52

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.

18 June 2024

54

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.

18 June 2024

55

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

18 June 2024

57

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality

18 June 2024

58

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer

18 June 2024

59

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Next-generation sequencing transforms today's biology

18 June 2024

61

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Real-time DNA sequencing using detection of pyrophosphate release

18 June 2024

62

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

High-throughput oncogene mutation profiling in human cancer

18 June 2024

63

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Complex landscapes of somatic rearrangement in human breast cancer genomes

18 June 2024

64

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Laser capture microdissection

18 June 2024

65

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Sequence-based cancer genomics: progress, lessons and opportunities

18 June 2024

66

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Transcriptome sequencing to detect gene fusions in cancer

18 June 2024

67

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Applications of next-generation sequencing technologies in functional genomics

18 June 2024

68

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.

18 June 2024

69

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients

18 June 2024

70

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line

18 June 2024

71

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

The landscape of somatic copy-number alteration across human cancers

18 June 2024

72

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls

18 June 2024

73

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors

18 June 2024

74

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays

18 June 2024

75

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

GENE SEQUENCING: The Race for the $1000 Genome

18 June 2024

76

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Characterization of single-nucleotide polymorphisms in coding regions of human genes

18 June 2024

77

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Quality and completeness of SNP databases

18 June 2024

78

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

dbSNP: the NCBI database of genetic variation

18 June 2024

79

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Common genetic variation and human disease

18 June 2024

80

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genotyping platforms for mass-throughput genotyping with SNPs, including human genome-wide scans

18 June 2024

81

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

18 June 2024

82

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays

18 June 2024

83

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Toward genome-wide SNP genotyping

18 June 2024

84

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Evidence for a colorectal cancer susceptibility locus on chromosome 3q21-q24 from a high-density SNP genome-wide linkage scan

18 June 2024

85

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.

18 June 2024

86

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk

18 June 2024

87

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia

18 June 2024

88

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genome-wide analysis of survival in early-stage non-small-cell lung cancer

18 June 2024

89

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients

18 June 2024

90

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia

18 June 2024

91

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genome remodelling in a basal-like breast cancer metastasis and xenograft

18 June 2024

92

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Prognostic significance of genetic alterations detected by high-density single nucleotide polymorphism array in gastric cancer.

18 June 2024

93

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Microarray-based expression profiling and informatics

18 June 2024

94

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

18 June 2024

95

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma

18 June 2024

96

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

18 June 2024

97

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Gene-expression profiles predict survival of patients with lung adenocarcinoma

18 June 2024

100

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Delineation of prognostic biomarkers in prostate cancer

18 June 2024

102

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

18 June 2024

104

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients

18 June 2024

105

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

18 June 2024

107

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

MicroRNA signatures in human cancers

18 June 2024

108

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.

18 June 2024

109

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

MicroRNA expression profiling using microarrays

18 June 2024

110

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

MicroRNAs in clinical oncology: at the crossroads between promises and problems

18 June 2024

111

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

18 June 2024

112

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.

18 June 2024

113

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

18 June 2024

Epigenetics in cancer

114

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Proteomic applications for the early detection of cancer

18 June 2024

115

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models

18 June 2024

116

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Mass spectrometry: uncovering the cancer proteome for diagnostics

18 June 2024

117

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts.

18 June 2024

118

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Biomarker discovery for ovarian cancer using SELDI-TOF-MS.

18 June 2024

119

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers

18 June 2024

120

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins

18 June 2024

121

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry

18 June 2024

122

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Studying cellular processes and detecting disease with protein microarrays

18 June 2024

124

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays

18 June 2024

125

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Protein biochips: the calm before the storm

18 June 2024

126

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Human Cancer Genome Project moving forward despite some doubts in community

18 June 2024

127

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.

18 June 2024

128

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

18 June 2024

129

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Identification of a new prostate cancer susceptibility locus on chromosome 8q24.

18 June 2024

130

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma

18 June 2024

131

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

18 June 2024

132

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genome-wide examination of genetic variants associated with response to platinum-based chemotherapy in patients with small-cell lung cancer

18 June 2024

133

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

18 June 2024

134

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Molecular networks as sensors and drivers of common human diseases

18 June 2024

135

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

The cancer genome anatomy project: building an annotated gene index

18 June 2024

136

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

The interactive online SKY/M-FISH & CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence

18 June 2024

137

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Implementation of GenePattern within the Stanford Microarray Database.

18 June 2024

138

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

The Roche Cancer Genome Database (RCGDB).

18 June 2024

139

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

The Protein Information Resource

18 June 2024

140

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Human Protein Reference Database--2009 update

18 June 2024

141

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Has the revolution arrived?

18 June 2024

142

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

18 June 2024

143

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Multiple personal genomes await

18 June 2024

144

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

18 June 2024

145

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Systems medicine: a real approach for future personalized oncology?

18 June 2024

146

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management?

18 June 2024

147

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

18 June 2024

148

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

Biologists initiate plan to map human proteome

18 June 2024

151

1 reference

https://api.crossref.org/works/10.1158/1541-7786.MCR-10-0264

18 June 2024

Identifiers

1 reference

23 August 2017

1 reference